2007 House Bill 5394

Democratic clinical drug trials regulation package

Introduced in the House

Oct. 31, 2007

Introduced by Rep. Gary McDowell (D-107)

To authorize fines of up to $250,000, and up to $1 million on a third or subsequent violation, for a pharmaceutical maker that fails to report information about human clinical trials conducted or sponsored in this state, as House Bill 5389 would mandate.

Referred to the Committee on Health Policy